Carnitine ratio: Acyl carnitine / free carnitine
| Material: | 1 ml serum / plasma |
| Methods: | Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie | Reference range | Men: 24,6 – 51,0 µmol/l Women: 17,9 – 45,5 µmol/l Children: please refer to findings report |
| Indication | Suspicion of metabolic disorders (symptoms such as muscular weakness, cardiomyopathy, encephalopathy, hepatopathy etc.). Organic acidurias, disturbances of the degradation of fatty acids (ß-oxidation cycle), disturbances of transport of the fatty acid (carnitine-cycle). Besides these primary metabolic disorders, there are decreased free carnitine levels in the following situations: Long-term carnitine-free diet, valproic acid medication, hemodialysis, from the 12th week of pregnancy. |
| External services | ja MVZ Dr. Eberhard & Partner Dortmund |
More Results for the letter C
- C-peptide in the serum (CPEP)
- C1-esterase inhibitor (C1-INH) (C1EA, C1EH)
- Activity evaluation, protein evaluation
- C2-complement (C2S)
- C3-complement in the serum (C3)
- C3-nephritis factor (C3NF)
- C3NeF
- C4-complement in the serum (C4)
- CA 125 (CA 125)
- CA 15-3 (CA15)
- CA 19-9 (CA19)
- CA 72-4 (CA72)
- Cadmium (CAD)
- Cd
- Caeruloplasmin (α2-) (CAER(a2))
- Caffeine (COFF)
- Calcitonin (CALC)
- hCT, human calcitonin
- Calcium in serum (CA)
- Ca
- Calcium in urine (CAU)
- Calcium, ionized, in serum (CAI)
- Calprotectin (ECALP)
- Calymmatobacterium granulomatis (CALY)
- Donovaniosis
- Campylobacter jejuni/coli infection (KCAMP, ECAMP, CAMPG, CAMPA)
- Canary serum, feather, excrement antibodies (IgG) (CANA)
- Candida infection (KCAND)
- Cannabinoids (CANN)
- Tetrahydrocannabinol, delta-9 THC, cannabis, weed, marihuana, hash
- Carbamazepine (CARB)
- Carboxyhemoglobin (COHB)
- CO-Hb
- Cardiac muscle antibodies (HMA)
- Carnitine ratio: Acyl carnitine / free carnitine (CARNF)
- Carotene (β-) (CARO(b))
- Group of carotenoids with provitamine A activity
- Cartilage autoantibodies (KNOR)
- Catecholamines in plasma (KATP)